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Background: The impact of anesthetic equipment on clinical practice parameters associated with development of
acute respiratory distress syndrome (ARDS) has not been extensively studied. We hypothesized a change in anesthesia
machines would be associated with parameters associated with lower rates of ARDS.
Methods: We performed a retrospective cohort study on a subset of data used to evaluate intraoperative ventilation.
Patients included adults receiving a non-cardiac, non-thoracic, non-transplant, non-trauma, general anesthetic between
2/1/05, and 3/31/09 at the University of Michigan. Existing anesthesia machines (Narkomed IIb, Drager) were exchanged
for new equipment (Aisys, General Electric). The initial subset compared the characteristics of patients anesthetized
between 12/1/06 and 1/31/07 (pre) with those between 4/1/07 and 5/30/07 (post). An extended subset examined
cases two years pre and post exchange. Using the standard predicted body weight (PBW), we calculated and compared
the tidal volume (total Vt and mL/kg PBW) as well as positive end-expiratory pressure (PEEP), peak inspiratory pressure
(PIP), Delta P (PIP-PEEP), and FiO2.
Results: A total of 1,414 patients were included in the 2-month pre group and 1,635 patients included in the post
group. Comparison of ventilation characteristics found statistically significant differences in median (pre v post): PIP
(26 ± 6 v 21 ± 6 cmH2O,p < .001), Delta P (24 ± 6 v 19 ± 6 cmH2O, p < .001), Vt (588 ± 139 v 562 ± 121 ml, p < 0.001;
9.3 ± 2.2 v 9.0 ± 1.9 ml/kg predicted body weight, p < .001), FiO2 (0.57 ± 0.17 v 0.52 ± 0.18, p < .001). Groups did not
differ in age, ASA category, PBW, or BMI. The two year subgroup had similar parameters. Risk adjustment resulted
in minimal differences in the analysis. New anesthesia machines were associated with a non-statistically significant
reduction in postoperative ARDS.
Conclusions: In this study, a change in ventilator management was associated with an anesthesia machine exchange.
The smaller Vt and lower PIP noted in the post group may imply a lower risk of volutrauma and barotrauma, which
may be significant in at-risk populations. However, there was not a statistically significant reduction in the incidence of
post-operative ARDS.
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Low volume, low pressure mechanical ventilation has
been shown to decrease mortality in critically ill patients
with acute lung injury [1,2]. The intraoperative use of
low tidal volumes has been associated with faster extu-
bation and less reintubation in patients, while larger
tidal volumes are associated with increased risk of post-
operative organ dysfunction after cardiac surgery [3,4].
Larger tidal volumes are also a risk factor for respiratory
failure after pneumonectomy [5]. Other clinical studies
have shown that intraoperative low volume, low pressure
ventilation decreases systemic inflammation and pre-
vents pulmonary inflammation, and recent data suggests
reduced drive pressure (ΔP) may be associated with a re-
duction in post-operative acute respiratory distress syn-
drome (ARDS) [6-8]. Despite the putative benefits of
intraoperative low volume, low pressure ventilation, par-
ticularly in patients at risk for ARDS, anesthesiologists
rarely use low volume ventilation [4,9].
Until recently, the accurate delivery of preset tidal
volumes was difficult. Anesthesiologists typically used
mechanically-set volume-cycled ventilators to support
patients intraoperatively. These ventilators allowed an-
esthesiologists to set the tidal volume and either the
driving pressure or the inspiratory time (sometimes
through manipulation of the respiratory rate and I:E ratio.)
However, the actual volume delivered would vary based
on breathing circuit compliance, chest compliance, and
fresh gas flow. Newer microprocessor-controlled venti-
lators with automatic compensation for tube compli-
ance and varying fresh gas flow have been shown to be
more accurate at delivering small tidal volumes under
conditions of both normal and low lung compliance
[10]. They also allow the user more control over respira-
tory parameters.
We hypothesized that the change to a microprocessor-
controlled ventilator would result in a lowering of intra-
operative tidal volumes and lower inspiratory pressures
associated with the development of ARDS.
Methods
This study was a retrospective cohort analysis conducted
using a subset of data previously described [8]. In brief,
Institutional Review Board approval was obtained for
this cohort study at The University of Michigan Health
System (IRB-MED, Ann Arbor, MI), a large, quaternary
care facility. All data were de-identified prior to analysis,
and a waiver of consent was obtained for this study. All
cases recorded in the anesthesia information manage-
ment system (Centricity, General Electric Healthcare,
Waukesha, WI) from 06/01/2004 to 06/01/2009 were
screened for inclusion. Cases on the cardiac, thoracic,
transplant, trauma, and vascular surgery services were
excluded, as were cases with no recorded service.Between February and March 2007, 63 anesthesia ma-
chines at the University of Michigan Hospital were ex-
changed in 8-10 room blocks from Drager Narkomed
IIb to GE Aisys. Hence, all cases from February 1, 2007
to March 31, 2007 were excluded. No Narcomed devices
were in use starting April 1, 2007. We then compared
ventilation parameters on a subset for the two months
before (December 1, 2006 to January 31, 2007) to the
two months after (April 1, 2007 to May 30, 2007) to
examine a possible immediate effect on ventilation. In
order to determine if the change was durable and if
there was an impact on development of ARDS, the two
years before (February 1, 2005 to January 31, 2007) vs.
the two years after (April 1, 2007 to March 31, 2009) the
ventilator change were examined.
Preoperative data were prospectively collected from
routine clinical documentation that was entered into the
anesthesia information management system. The record
includes a structured preoperative history and physical
examination. Data abstracted from the preoperative his-
tory included basic demographic and comorbidity infor-
mation necessary for the management of the critically ill
or suggestive of the need for critical care services. A de-
tailed description of variable definitions is included in
previous publications [8]. Free text entries were hand-
coded by the research team for analysis.
Unique hospital admissions were considered as the
base unit for analysis. Admissions containing multiple
anesthetic cases were analyzed from the last case of
the admission or the last case prior to development of
ARDS, as appropriate. Records from the final anesthetic
of each admission were also used to determine pre-
operative comorbidities and ASA status. The ASA sta-
tus recorded for this final case was collapsed into a
binary variable reflecting whether a patient was considered
ASA 1-2 or ASA 3-5.
Intraoperative physiologic and ventilator data were ac-
quired using an automated, validated electronic interface
from the anesthesia machines and physiologic monitors
(Solar 9500; General Electric Healthcare). Fraction in-
spired oxygen (FiO2), peak inspiratory pressure (PIP), ex-
haled Vt, PEEP, oxyhemoglobin saturation (SpO2), drive
pressure (ΔP), and respiratory rate were obtained and an-
alyzed for median values to eliminate spurious and iso-
lated values. The number of ten-minute epochs of median
PIP >30 cmH2O, and number of ten-minute epochs of
median Vt > 12 cc/kg PBW from the time of incision to
the end of anesthesia were examined as markers of contin-
ued high pressure and/or high volume ventilation.
Case times were validated using electronically docu-
mented heart rate from electrocardiogram or electronic-
ally documented start and end. Only cases with positive
times were included. Cases from patients graded as ASA
classification 6 were excluded.
Table 1 Preoperative demographics and intraoperative data of patients 2 months before and after ventilator exchange
Preoperative variable Before vent exchange (n = 1414) After vent exchange (n = 1635) p
Age (mean ± SD, yr) 51 ± 16 51 ± 16 0.713
Male (n,%) 628 (44%) 731 (44%) 0.898
Patient ASA 3,4 or 5 (n,%) 443 (31%) 536 (32%) 0.413
Emergent Case (n,%) 46 (3%) 54 (3%) 0.980
Predicted Body Weight (mean ± SD, kg) 64 ± 11 63 ± 10 0.316
Weight (mean ± SD, kg) 85 ± 24 85 ± 24 1
BMI (mean ± SD, kg/m2) 29 ± 7 29 ± 8 0.517
Smoker
Former (n,%) 247 (18%) 304 (19%) 0.448
Current (n,%) 228 (16%) 267 (16%) 0.917
Lung Disease (n,%) 10 (0.7%) 8 (0.5%) 0.585
Asthma (n,%) 114 (8%) 134 (8%) 0.946
COPD (n,%) 73 (5%) 100 (6%) 0.291
Diabetes (n,%) 178 (13%) 218 (13%) 0.578
Hypertension (n,%) 506 (36%) 616 (38%) 0.297
Coronary Artery Disease (n,%) 93 (7%) 126 (8%) 0.257
Congestive Heart Failure (n,%) 40 (3%) 53 (3%) 0.579
Chronic Kidney Disease (n,%) 76 (5%) 110 (7%) 0.139
Hepatic Disease (n,%) 19 (1%) 33 (2%) 0.195
Alcohol Abuse (n,%) 45 (3%) 47 (3%) 0.697
Current Steroid Therapy (n,%) 46 (3%) 61 (4%) 0.538
Intraoperative variable Before vent exchange (n = 15,481) After vent exchange (n = 18,945) p
Ventilatory Parameters (case medians)
PIP (mean ± SD, cmH2O) 26 ± 6 21 ± 6 < 0.001
PEEP (mean ± SD, cmH2O) 2 ± 1.4 1.6 ± 2.6 < 0.001
ΔP (mean ± SD, cmH2O) 24 ± 6 19 ± 6 < 0.001
RR (mean ± SD, breath per minute) 11 ± 2.5 11 ± 3 < 0.001
Vt (mean ± SD, ml) 588 ± 139 562 ± 121 < 0.001
Vt cc/kg PBW (mean ± SD, ml) 9.3 ± 2.19 9.0 ± 1.88 < 0.001
FiO2 (mean ± SD,%) 57.2 ± 0.17 51.8 ± 18 < 0.001
cc/kg PBW ≤ 6 (n,%) 90 (6%) 104 (6%) 1
cc/kg PBW ≤ 8 (n,%) 316 (22%) 433 (27%) 0.009
Epochs of 10 minutes:
PIP > 30 cmH2O 3.5 ± 7.5 1.5 ± 5 < 0.001
Vt > 12 cc/kg PBW 1.8 ± 5 0.9 ± 4 < 0.001
Colloid use (n,%) 198 (14%) 184 (11%) 0.026
Crystalloid volume (median, 25th,75th, ml) 2000 (1200,3000) 1900 (1000,2700) < 0.001
Case Length (mean ± SD, minutes) 220 ± 124 208 ± 124 0.005
Transfusion (n,%) 79 (6%) 76 (5%) 0.248
PRBC (n,%) 77 (5%) 73 (5%) 0.244
FFP (n,%) 14 (1%) 17 (1%) 1
Platelets (n,%) 7(0.5%) 8 (0.5%) 0.813
ASA = American Society of Anesthesiology Classification, BMI = body mass index, COPD = chronic obstructive pulmonary disease, PIP = peak inspiratory pressure,
PEEP = positive end expiratory pressure, RR = respiratory rate, Vt = tidal volume, PBW = predicted body weight, FiO2 = fraction inspired oxygen, PBW = predicted
body weight, PRBC = packed red blood cells, FFP = fresh frozen plasma.
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ally entered by the anesthetic team into the anesthesia
information management system were examined. From
the recorded intraoperative PaO2 values and FiO2 the
P/F ratio was calculated for each available blood gas.
Volumes of crystalloid, colloid, units of packed erythro-
cytes (PRBC), units of fresh frozen plasma, and units of
platelets were also obtained from the electronic anesthetic
record.
The subpopulation of patients who went on to develop
ARDS was identified from a prospectively collected re-
search dataset of all adult critical care patients on venti-
lators at the University of Michigan Medical Center
who were screened for entry into ARDS studies. Only
patients receiving mechanical ventilation after their
anesthetic were screened for ARDS. ARDS was diagnosed
through analysis of the patient’s ventilator status, arterial
blood gases, chest x-ray, and clinical documentation. Pa-
tients were deemed positive for the primary outcome of
ARDS if they met the Berlin criteria for ARDS between
postoperative days 0 and 7, inclusive. Charts of patients
who developed ARDS on the day of their operation were
examined by one of the authors (JMB), and those with a
diagnosis of ARDS prior to their anesthetic were ex-
cluded. Finally, mortality data were collected from an in-
stitutional death database to compare the mortality of
the risk-matched groups both with and without ARDS inFigure 1 Scatterplots of average ventilation parameters over 2 month
practice. Significant changes were seen in peak inspiratory pressure (PIP) a
expiratory pressure, RR = respiratory rate.order to determine the risk presented to patients who de-
velop ARDS. This database is constructed using multiple
resources including in-hospital mortality, failed follow-up
at clinic visits and the social security death master file.
Statistical Analysis
Statistical analysis was performed using R version 2.15.2
(R Foundation for Statistical Computing, Vienna, Austria).
Descriptive statistics were used to summarize the before
and after ventilator change groups. Differences between
groups were tested using the chi-square test, Fisher’s exact
test, t-test, or Mann-Whitney U test, as appropriate, with
p-values < 0.05 indicating statistical significance.
To reduce confounding and determine if changes in
population characteristics may have impacted the devel-
opment of postoperative ARDS, we performed matching
on the likelihood for developing postoperative ARDS
within both the two-month and two-year cohorts. These
scores were calculated using logistic regression on vari-
ables that likely increase the risk of postoperative ARDS,
from our prior work [8]. This included preoperative
patient characteristics as well as intraoperative use of
blood products. Before-ventilator-change cases were
then matched 1:1 with after-ventilator-change cases
using a nearest neighbor match, with a caliper of .001
on the risk score. Standardized mean differences were
calculated to assess balance in the variables includeds before and 2 months after new machines are integrated into
nd drive pressure (ΔP). Vt = tidal Volume, PEEP = positive end
Table 2 Preoperative demographics and intraoperative data of patients 2 years before and after ventilator exchange
Preoperative variable Before vent exchange (n = 15,481) After vent exchange (n = 18,945) p
Age (mean ± SD, yr) 50 ± 17 52 ± 16 < 0.001
Male (n,%) 6936 (45%) 8619 (46%) 0.776
Patient ASA 3,4 or 5 (n,%) 4207 (27%) 6259 (33%) < 0.001
Emergent Case (n,%) 697 (4%) 830 (4%) 0.605
Predicted Body Weight (mean ± SD, kg) 64 ± 11 64 ± 11 0.939
Weight (mean ± SD, kg) 83 ± 22 84 ± 22 < 0.001
BMI (mean ± SD, kg/m2) 28.6 ± 6.9 29.1 ± 7.3 < 0.001
Smoker
Former (n,%) 2717 (18%) 4009 (21%) < 0.001
Current (n,%) 2556 (17%) 3024 (16%) 0.174
Lung Disease (n,%) 45 (0.3%) 59 (0.3%) 0.802
Asthma (n,%) 1153 (7%) 1633 (9%) < 0.001
COPD (n,%) 744 (5%) 1046 (6%) 0.003
Diabetes (n,%) 1758 (11%) 2658 (14%) < 0.001
Hypertension (n,%) 5055 (33%) 7409 (39%) < 0.001
Coronary Artery Disease (n,%) 1143 (7%) 1633 (9%) < 0.001
Congestive Heart Failure (n,%) 378 (2%) 676 (4%) 0.545
Chronic Kidney Disease (n,%) 717 (5%) 1157 (6%) < 0.001
Hepatic Disease (n,%) 235 (2%) 452 (2%) < 0.001
Alcohol Abuse (n,%) 535 (4%) 582 (3%) 0.049
Current Steroid Therapy (n,%) 341 (2%) 658 (4%) < 0.001
Intraoperative variable Before vent exchange (n = 15,481) After vent exchange (n = 18,945) p
Ventilatory Parameters (case medians)
PIP (mean ± SD, cmH2O) 25.4 ± 5.9 20.2 ± 6.1 < 0.001
PEEP (mean ± SD, cmH2O) 1.9 ± 1.2 2.7 ± 2.8 < 0.001
ΔP (mean ± SD, cmH2O) 23.4 ± 5.7 17.5 ± 5.6 < 0.001
RR (mean ± SD, breath per minute) 11.0 ± 2.5 10.7 ± 2.5 < 0.001
Vt (mean ± SD, ml) 587 ± 146 543 ± 118 < 0.001
Vt cc/kg PBW (mean ± SD, ml) 9.35 ± 2.29 8.67 ± 1.95 < 0.001
FiO2 (mean ± SD,%) 55.3 ± 16 54.1 ± 19 < 0.001
cc/kg PBW ≤ 6 (n,%) 1221 (8%) 1643 (9%) < 0.001
cc/kg PBW ≤ 8 (n,%) 3534 (23%) 6465 (34%) < 0.001
Epochs of 10 minutes:
PIP > 30 cmH2O 3.1 ± 7.1 1.2 ± 4.2 < 0.001
Vt > 12 cc/kg PBW 1.92 ± 4.9 0.8 ± 3.4 < 0.001
Colloid use (n,%) 1585 (10%) 1828 (10%) 0.072
Crystalloid volume (median, 25th,75th, ml) 2000 (1200,3000) 2200 (1600,3100) < 0.001
Case Length (mean ± SD, minutes) 214 ± 125 206 ± 122 < 0.001
Transfusion (n,%) 793 (5%) 880 (5%) 0.043
PRBC (n,%) 727 (5%) 810 (4%) 0.064
FFP (n,%) 175 (1%) 159 (1%) 0.007
Platelets (n,%) 91 (0.6%) 104 (0.5%) 0.685
ASA = American Society of Anesthesiology Classification, BMI = body mass index, COPD = chronic obstructive pulmonary disease, PIP = peak inspiratory pressure,
PEEP = positive end expiratory pressure, RR = respiratory rate, Vt = tidal volume, PBW = predicted body weight, FiO2 = fraction inspired oxygen, PBW = predicted
body weight, PRBC = packed red blood cells, FFP = fresh frozen plasma.
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good balance. Appropriate descriptive statistics and tests
were again used to compare variables between groups after
matching.
Results
A total of 1414 and 1635 cases were identified in the
two-month periods before and after the anesthesia ma-
chine exchange. There were no statistically significant
differences between the groups in their preoperative
demographics (Table 1). Differences were found in the
intraoperative use of colloids, the amount of crystalloid
administered, and multiple ventilatory parameters. These
included a substantial reduction in the peak inspiratory
pressure, a decrease in the amount of PEEP, a decrease
in the median Vt, and a decrease in the median drive
pressure (Figure 1). There was also a substantial reduc-
tion in the number of epochs of high peak pressures
(>30 cm H2O), and epochs of Vt greater than 12 cc/kg
PBW, and an increase in the number of cases being man-
aged with Vt of < 8 cc/kg PBW.
For the two-year pre/post cohorts, a total of 15,481
and 18,945 cases were identified before and after the
anesthesia machine exchange. There were a number of
statistically significant differences between the groups in
their preoperative demographics (Table 2). In particularFigure 2 Scatterplots of average ventilation parameters over 2 month
practice. Significant changes were seen in peak inspiratory pressure (PIP) a
expiratory pressure, RR = respiratory rate.there was an increase in the preoperative use of steroids
and an increase in patients who were former smokers.
Intraoperative differences were extensive. The reductions
in the ventilatory parameters over the two-month ana-
lysis were durable in the two-year analysis (Figure 2). In
addition, there was a statistically significant reduction in
use of blood products. A statistically significant increase
in the use of colloids was not seen in the two-year co-
hort analysis.
The risk score match resulted in 864 and 13250
matched pairs for two months and two years respect-
ively. After matching, all standardized mean differences
were less than 10%, indicating good balance between
groups. No significant differences remained between the
preoperative characteristics in the two matched groups
(Tables 3 and 4). After matching on preoperative risk,
there remained a statistically significant reduction in
many parameters associated with the development of
ARDS and a statistically non-significant reduction in the
incidence of postoperative ARDS (Tables 5 and 6). There
was no reduction in mortality in any group.
Discussion
The conclusions of this study are 1) The introduction of
a new anesthesia machine with advanced ventilator cap-
abilities was associated with immediate and dramatics before and 2 months after new machines are integrated into
nd drive pressure (ΔP). Vt = Tidal Volume, PEEP = positive end
Table 3 Preoperative demographics and intraoperative data of patients 2 months before and after ventilator exchange
after risk matching
Preoperative variable Before vent exchange (n = 864) After vent exchange (n = 864) p
Age (mean ± SD, yr) 49 ± 16 48 ± 16 0.656
Male (n,%) 358 (41%) 362 (42%) 0.884
Patient ASA 3,4 or 5 (n,%) 198 (23%) 188 (22%) 0.603
Emergent Case (n,%) 24 (3%) 16 (2%) 0.263
Predicted Body Weight (mean ± SD, kg) 64 ± 10.5 63 ± 10.5 0.294
Weight (mean ± SD, kg) 84 ± 23.5 84 ± 22.8 0.658
BMI (mean ± SD, kg/m2) 28.9 ± 7.4 29.0 ± 7.3 0.854
Smoker
Former (n,%) 141 (16%) 134 (16%) 0.693
Current (n,%) 138 (16%) 132 (15%) 0.74
Lung Disease (n,%) 3 (0.3%) 5 (0.6%) 0.726
Asthma (n,%) 71 (8%) 72 (8%) 1
COPD (n,%) 20 (2%) 19 (2%) 1
Diabetes (n,%) 86 (10%) 73 (8%) 0.381
Hypertension (n,%) 250 (29%) 230 (27%) 0.308
Coronary Artery Disease (n,%) 23 (3%) 18 (2%) .527
Congestive Heart Failure (n,%) 12 (1%) 12 (1%) 1
Chronic Kidney Disease (n,%) 21 (2%) 20 (2%) 1
Hepatic Disease (n,%) 11 (1%) 11 (1%) 1
Alcohol Abuse (n,%) 27 (3%) 21 (2%) 0.464
Current Steroid Therapy (n,%) 24 (3%) 25 (3%) 1
Intraoperative variable Before vent exchange (n = 864) After vent exchange (n = 864) p
Ventilatory Parameters (case medians)
PIP (mean ± SD, cmH2O) 25.3 ± 5.7 20.3 ± 6.2 < 0.001
PEEP (mean ± SD, cmH2O) 2.0 ± 1.3 1.5 ± 2.5 < 0.001
ΔP (mean ± SD, cmH2O) 23.3 ± 5.4 18.8 ± 5.6 < 0.001
RR (mean ± SD, breath per minute) 11.0 ± 2.3 10.5 ± 2.2 < 0.001
Vt (mean ± SD, ml) 587 ± 146 559 ± 125 < 0.001
Vt cc/kg PBW (mean ± SD, ml) 9.33 ± 2.22 8.98 ± 1.94 < 0.001
FiO2 (mean ± SD,%) 55.5 ± 16 51.2 ± 18 < 0.001
cc/kg PBW ≤ 6 (n,%) 62 (7%) 63 (7%) 1
cc/kg PBW ≤ 8 (n,%) 188 (22%) 219 (34%) 0.089
Epochs of 10 minutes:
PIP > 30 cmH2O 2.9 ± 6.4 1.4 ± 4.5 < 0.001
Vt > 12 cc/kg PBW 1.7 ± 4.3 0.9 ± 3.6 < 0.001
Colloid use (n,%) 51 (5.9%) 47 (5.4%) 0.755
Crystalloid volume (median, 25th,75th, ml) 1950 (1100, 2700) 1900 (1000,2500) 0.111
Case Length (mean ± SD, minutes) 198 ± 103 195 ± 104 0.531
Transfusion (n,%) 17 (2%) 15 (2%) 0.858
PRBC (n,%) 16 (2%) 15 (5%) 1
FFP (n,%) 2 (0.2%) 4 (0.5%) 0.683
Platelets (n,%) 2 (0.2%) 1 (0.1%) 1
ASA = American Society of Anesthesiology Classification, BMI = body mass index, COPD = chronic obstructive pulmonary disease, PIP = peak inspiratory pressure,
PEEP = positive end expiratory pressure, RR = respiratory rate, Vt = tidal volume, PBW = predicted body weight, FiO2 = fraction inspired oxygen, PBW = predicted
body weight, PRBC = packed red blood cells, FFP = fresh frozen plasma.
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Table 4 Preoperative demographics and intraoperative data of patients 2 years before and after ventilator exchange
after risk matching
Preoperative variable Before vent exchange (n = 13,250) After vent exchange (n = 13,250) p
Age (mean ± SD, yr) 51 ± 16 50 ± 16 < 0.001
Male (n,%) 5932 (45%) 5956 (45%) 0.776
Patient ASA 3,4 or 5 (n,%) 3788 (28.6%) 3604 (27.2%) 0.012
Emergent Case (n,%) 591 (4.5%) 588 (4.4%) 0.952
Predicted Body Weight (mean ± SD, kg) 63 ± 10.6 64 ± 10.6 0.247
Weight (mean ± SD, kg) 83 ± 22 83 ± 22 0.568
BMI (mean ± SD, kg/m2) 29 ± 7 29 ± 7 0.906
Smoker
Former (n,%) 2410 (18.2%) 2637 (19.9%) < 0.001
Current (n,%) 2182 (16.5%) 2195 (16.6%) 0.843
Lung Disease (n,%) 37 (0.3%) 33 (0.2%) 0.72
Asthma (n,%) 1054 (8%) 998 (7.5%) 0.206
COPD (n,%) 664 (5%) 643 (4.9%) 0.57
Diabetes (n,%) 1531 (12%) 1477 (11%) 0.305
Hypertension (n,%) 4670 (35%) 4366 (33%) < 0.001
Coronary Artery Disease (n,%) 1028 (8%) 989 (7%) 0.379
Congestive Heart Failure (n,%) 307 (2%) 323 (2%) 0.545
Chronic Kidney Disease (n,%) 616 (5%) 605 (5%) 0.77
Hepatic Disease (n,%) 212 (2%) 277 (2%) 0.003
Alcohol Abuse (n,%) 467 (4%) 396 (3%) 0.015
Current Steroid Therapy (n,%) 304 (2%) 415 (3%) < 0.001
Intraoperative Variable Before vent exchange (n = 13,250) After vent exchange (n = 13,250) p
Ventilatory Parameters (case medians)
PIP (mean ± SD, cmH2O) 25.5 ± 6 20 ± 6 < 0.001
PEEP (mean ± SD, cmH2O) 1.9 ± 1.2 2.7 ± 2.8 0.257
ΔP (mean ± SD, cmH2O) 23.6 ± 6 17.3 ± 6 < 0.001
RR (mean ± SD, breath per minute) 11 ± 2.5 11 ± 2.5 < 0.001
Vt (mean ± SD, ml) 590 ± 144 541 ± 120 < 0.001
Vt cc/kg PBW (mean ± SD, ml) 9.41 ± 2.26 8.62 ± 1.96 < 0.001
FiO2 (mean ± SD) 55 ± 16 54 ± 19 < 0.001
cc/kg PBW ≤ 6 (n,%) 953 (7%) 1223 (9%) < 0.001
cc/kg PBW ≤ 8 (n,%) 2915 (22%) 4584 (35%) < 0.001
Epochs of 10 minutes:
PIP > 30 cmH2O 3.2 ± 7.1 1.1 ± 4 < 0.001
Vt > 12 cc/kg PBW 2 ± 4.8 0.7 ± 3.1 < 0.001
Colloid use (n,%) 1202 (9%) 1157 (9%) 0.343
Crystalloid volume (median, 25th,75th, ml) 2000 (1300,3000) 2000 (1500,3000) < 0.001
Case Length (mean ± SD, minutes) 215 ± 122 197 ± 116 < 0.001
Transfusion (n,%) 560 (4%) 554 (4%) 0.878
PRBC (n,%) 509 (4%) 513 (4%) 0.924
FFP (n,%) 103 (0.8%) 91 (0.7%) 0.428
Platelets (n,%) 64 (<0.5%) 60 (<0.5%) 0.787
ASA = American Society of Anesthesiology Classification, BMI = body mass index, COPD = chronic obstructive pulmonary disease, PIP = peak inspiratory pressure,
PEEP = positive end expiratory pressure, RR = respiratory rate, Vt = tidal volume, PBW = predicted body weight, FiO2 = fraction inspired oxygen, PBW = predicted
body weight, PRBC = packed red blood cells, FFP = fresh frozen plasma.
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Table 5 28 day and 90 day mortality and acute lung
injury incidence after matching on the 2 month cohort





28 day Mortality 2 (0.2%) 3 (0.3%) 1
90 day Mortality 8 (0.9%) 6 (0.7%) 0.79
Acute Lung Injury
within 7 days
3 (0.3%) 0 (0.0%) 0.25
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http://www.biomedcentral.com/1471-2253/14/44reduction in the PIP delivered to patients, 2) There was
also a statically significant reduction in the Vt delivered
to patients, the number of epochs greater than 12 cc/kg
PBW, and epochs where patients received peak inspira-
tory pressures greater than 30 cm H2O, 3) The reduc-
tions in these settings were durable over a two-year
period, 4) The settings were consistent with settings that
have been associated with a reduction in the incidence
of ARDS, and 5) There was a non-significant reduction
in the incidence of ARDS after the introduction of the
new anesthesia machine. Despite a significant change in
the patient population, this non-significant reduction
remained after matching.
In our previous work, we demonstrated that the devel-
opment of postoperative ARDS was associated with a
high mortality rate. We also found that intraoperative
ventilator management, in particular the reduction of
the ΔP, may lessen the risk of developing ARDS [8].
Our institution’s introduction of a new anesthesia
machine that incorporated advanced microprocessor-
controlled ventilation into all operating rooms nearly
simultaneously offered a unique opportunity to exam-
ine the impact of ventilator features on ventilation
parameters. We have noted a continued reduction in pres-
sures and volumes over a several year period with a distinct
reduction in tidal volumes and pressures seen from 2007
to 2008 [11].
This new analysis of data from our prior study offered
the opportunity to determine if favorable changes in
ventilation occurred with the introduction of advanced
equipment. Furthermore, it offered the opportunity to
observe if there was a reduction in the development
of ARDS with the use of these improved parameters.
While a statistically significant reduction in ARDS was notTable 6 28 day and 90 day mortality and acute lung
injury incidence after matching on the 2 year cohort





28 day Mortality 83 (0.6%) 74 (0.6%) 0.522
90 day Mortality 190 (1.4%) 188 (1.4%) 0.959
Acute Lung Injury
within 7 days
20 (0.2%) 12 (0.1%) 0.216demonstrated in this study, there was a significant change
in the ventilation parameters associated with the develop-
ment of the condition.
The concept of ventilator induced lung injury has been
well established, and its avoidance is the currently pre-
ferred prevention and treatment modality for ARDS
[12]. Although the majority of published prospective
research has focused on reduced tidal volumes as the
primary endpoint, there exists substantial evidence that
increased ventilator pressures may be highly predictive
of ARDS associated mortality. In the ARDSnet ARMA
trial, a target ventilation of 4-8 cc/kg PBW with plateau
pressures < 30 cm H2O was compared to a ventilation
strategy using volumes of 12 cc/kg PBW and plateau
pressures < 50 cm H2O [2]. The absolute mortality re-
duction was found to be 9% in favor of the low tidal vol-
ume, low pressure group.
Additional data supports the reduction in pressures to
avoid the development of ARDS, particularly in the peri-
operative period. Licker and colleagues described the
hyperpressure index and its prediction of post-operative
ARDS in the thoracic surgery population [13,14]. In our
prior work, positive predictors of the development of
ARDS included higher ΔP and higher FiO2 [8].
New ventilator technologies have been demonstrated
to reduce the PIP during ventilation and by definition
produce lower ΔP. The premise behind these reduced
pressures is the use of a decelerating flow profile based
on pressure. Functionally, this was been demonstrated
by Rappaport and colleagues in a trial of volume con-
trolled ventilation vs. pressure limited ventilation in crit-
ically ill patients suffering from respiratory failure [15].
The study demonstrated lower PIP in addition to accel-
erated improvements in lung compliance. Guldager et al.
also demonstrated a reduction in PIP using pressure
control with a volume guarantee in patients with acute
respiratory failure using tidal volumes from 5 to 8 cc/kg
PBW [16]. Despite the previous literature from the crit-
ical care setting, this is the first evidence, to our know-
ledge, demonstrating a change in ventilation parameters
with the introduction of a new anesthesia machine. The
changes in parameters were consistent with strategies
suggested to reduce the incidence of ARDS. While the
data did not demonstrate this reduction we believe this
may very well be due to inadequate power. Nearly
30,000 patients would have to be enrolled in each group
to achieve a statistical power of 90%. Many of the venti-
lator changes could be the result of a change in patient
population and changes in anesthetic technique, in-
cluding a reduction in transfusions. To address these
concerns, we created a risk-matched cohort to examine
differences within the groups. While there continued to
be a reduction in ARDS cases, the reduction remained
statistically insignificant.
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http://www.biomedcentral.com/1471-2253/14/44This study has several limitations. Data were collected
as part of routine clinical care and were not subject to a
validation processes typically used in prospective trials.
Although data were entered using a predefined selection
process for each variable, there was no formal training
on the definitions for each variable. Free text, which is
allowed in all fields, was left to interpretation by the re-
search team. Despite these data collection limitations,
such data have been used frequently to develop models
in the literature and have correlated with data that
were prospectively collected by dedicated research
staff [17-19]. Additionally, the method of data collec-
tion regarding tidal volumes differed between the two
anesthesia machines and was not able to be corrected
for. The Aisys machine uses a corrected tidal volume ac-
counting for volumes lost due to circuit compliance
whereas the Narkomed IIb utilized a simple spirometer
that did not provide any correction. It is conceivable this
may impact the total Vt to such an extent that any docu-
mented change may indeed be non-significant, as the
compliance for a typical adult circuit on the Narkomed
IIb has been documented to be 2.75 ml/cm H2O. How-
ever, this should not have impacted the other observed
ventilation changes. Other reasons for the potential
change include the mode of ventilation. The Narkomed
IIb only provided one mode of mechanical ventilation,
volume controlled intermittent mandatory ventilation
with a maximal pressure setting that was manually set.
The Aisys provides a multitude of ventilation settings in-
cluding various forms of volume controlled and pressure
controlled ventilation. Unfortunately, the mode of venti-
lation is not recorded in our AIMS, but the standard set-
ting is pressure control with a volume guarantee, which,
from our experience, is by far the most common mode
used in our patient population. Furthermore, plateau
pressures are not recorded. Instead, we used PIP and ΔP
as surrogates. Next, the data are from a single, large, ter-
tiary care center, collected over several years. While this
is required for such an analysis, the patient population
may have changed with the introduction of the new
anesthesia machines. The database used to determine
whether patients had ARDS was developed using a screen-
ing mechanism requiring mechanical ventilation. Thus, it
is possible the true frequency of ARDS is underrepre-
sented. Additionally, we cannot be completely confident
the changes in ventilation parameters were only due to the
anesthesia machines and not due to a natural change in
ventilation decisions by the anesthesia providers. However,
we believe that changes during the two month periods be-
fore and after machine exchange would be unlikely due to
natural changes. Finally, the mortality data are based on
an internal death registry and may not capture mortality
of patients who were discharged to another long-term fa-
cility for ongoing care.Conclusions
Despite the limitations, this investigation provides evi-
dence that perioperative ventilation changes with the
introduction of new anesthesia machine. This may pro-
vide a new mechanism for the study of intraoperative
mechanical ventilation and its impact on the develop-
ment of ARDS. We have demonstrated that a new
anesthesia machine is clearly associated with a reduction
in ventilation parameters that are correlated with the de-
velopment of ARDS. The data were underpowered to
demonstrate a reduction in ARDS but was associated
with a non-statistically significant reduction in ARDS.
Additional studies are required to determine if such ef-
fect is seen at other institutions.
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